What documentation is required for Medicare to approve a rollator walker for a patient with osteoarthritis (Degenerative Joint Disease) of the knees and hip, currently requiring a cane for ambulation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

To document a rollator walker for Medicare approval in a patient with osteoarthritis of the knees and hip who currently uses a cane, a detailed medical necessity statement is required, including the patient's diagnosis, current mobility limitations, and need for additional support due to worsening symptoms, as supported by the 2019 American College of Rheumatology guideline 1. The documentation should include the patient's diagnosis of osteoarthritis affecting multiple joints (knees and hip), specifically noting ICD-10 codes such as M17.9 for knee osteoarthritis and M16.9 for hip osteoarthritis.

  • Document that the patient currently requires a cane but has progressed to needing additional support due to worsening pain, instability, or fall risk, as cane use is strongly recommended for patients with knee and/or hip OA in whom disease in 1 or more joints is causing a sufficiently large impact on ambulation, joint stability, or pain to warrant use of an assistive device 1.
  • Include objective findings from a physical examination showing decreased range of motion, pain with weight-bearing, gait instability, or other functional limitations.
  • Specify that the patient requires the rollator for mobility within the home (this is crucial for Medicare coverage) and that the device is necessary for activities of daily living.
  • Note any failed conservative treatments, such as weight loss, exercise programs, self-efficacy and self-management programs, tai chi, yoga, or cognitive behavioral therapy, and why a cane is no longer sufficient. Medicare typically requires that the rollator be prescribed by a physician with supporting documentation from physical therapy evaluations if available, as the device is considered durable medical equipment (DME) and requires clear evidence that it is medically necessary, not just convenient, and that less costly alternatives (like the current cane) are insufficient for safe mobility.

From the Research

Documentation Requirements for Medicare Approval

To obtain Medicare approval for a rollator walker for a patient with osteoarthritis of the knees and hip, the following documentation is necessary:

  • A thorough medical evaluation and diagnosis of osteoarthritis, including the patient's medical history, current symptoms, and treatment plan 2
  • Documentation of the patient's current mobility status, including their ability to ambulate with a cane and any limitations or difficulties they experience 3
  • An assessment of the patient's need for a rollator walker, including their balance, upper body strength, and dexterity 3
  • A prescription for a rollator walker from a qualified healthcare professional, including the patient's name, the type of device prescribed, and the medical reason for the prescription 3

Medical Necessity

To establish medical necessity for a rollator walker, the patient's healthcare provider must document that:

  • The patient has a medical condition that requires the use of a mobility assistive device, such as osteoarthritis of the knees and hip 2
  • The patient is unable to ambulate safely without the use of a mobility assistive device, such as a cane or rollator walker 3
  • The patient has tried other treatments, such as exercise therapy and physical modalities, and has not achieved sufficient relief from symptoms 4, 5, 6

Additional Considerations

When documenting the medical necessity for a rollator walker, the healthcare provider should also consider the following:

  • The patient's ability to use the device safely and effectively, including their balance, upper body strength, and dexterity 3
  • The patient's lifestyle and living situation, including their home environment and ability to navigate stairs or other obstacles 3
  • The patient's overall health and medical status, including any comorbidities or other medical conditions that may affect their ability to use a rollator walker 2

Related Questions

What are the treatment options for an 87-year-old patient with severe left hip osteoarthritis (OA) and osteopenia who fell onto their left hip, resulting in pain and stiffness, but no acute fracture?
What are the initial treatment recommendations for patients with arthritis (Arthritis) or osteoarthritis (Osteoarthritis)?
What pain management options are available for a 93-year-old patient with an arthritic knee, unable to bear weight, and on anticoagulant (blood thinner) therapy for Atrial Fibrillation (AFib) with a pacemaker?
What is the management for a 71-year-old female with severe right knee osteoarthritis (OA), diabetes (DM), hypertension (HTN), and hyperlipidemia, with normal blood values, and currently taking medications?
What is the diagnosis and recommended follow-up for a 63-year-old male presenting with left hip pain and radiographic evidence of osteoarthritis (OA) changes on hip X-ray, with no displaced fractures observed?
What antibiotic is safe during pregnancy in a patient with a urinary tract infection (UTI) and pyelonephritis?
What is the cause of a patient (Pt) having anisocoria (unequal pupil sizes)?
What is the significance of the Purple trial in the field of endoscopy, particularly for advanced colonoscopists and providers of Endoscopic Submucosal Dissection (ESD), Endoscopic Mucosal Resection (EMR), and Peroral Endoscopic Myotomy (POEM)?
What is the critical analysis of the PURPLE trial on Purastat (Purified bovine surfactant)?
What is the relationship between Valproate (Depakote) and elevated Liver Function Tests (LFTs), specifically Hepatotoxicity?
Is azathioprine (Imuran) safe during pregnancy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.